Atrial Fibrillation Surgery Market by Product and Geography - Forecast and Analysis 2022-2026

The atrial fibrillation surgery market share is expected to increase by USD 1.89 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 14.17%.

This atrial fibrillation surgery market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers atrial fibrillation surgery market segmentation by product (catheter ablation and surgical ablation) and geography (North America, Europe, Asia, and Rest of World (ROW)). The atrial fibrillation surgery market report also offers information on several market vendors, including Abbott Laboratories, AtriCure Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., CardioFocus Inc., General Electric Co., Johnson and Johnson, Medtronic Plc, Koninklijke Philips NV, Siemens Healthineers AG, MicroPort Scientific Corp., Boehringer Ingelheim International GmbH, Stereotaxis Inc, Tempus Labs Inc., Teleflex Inc., Lepu Medical Technology Beijing Co. Ltd., AngioDynamics Inc., Avanos Medical Inc., and OSYPKA AG among others.

What will the Atrial Fibrillation Surgery Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Atrial Fibrillation Surgery Market Size for the Forecast Period and Other Important Statistics

 

Atrial Fibrillation Surgery Market: Key Drivers, Trends, and Challenges

The advances in technology is notably driving the atrial fibrillation surgery market growth, although factors such as the high cost of ablation catheters may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the atrial fibrillation surgery industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Atrial Fibrillation Surgery Market Driver

The advances in technology is one of the key drivers supporting the atrial fibrillation surgery market growth. The technology offers high-resolution imagining of the heart tissues. This allows surgeons to pinpoint the exact location of the arrhythmia, improving the effectiveness of the procedure. The implementation of these types of devices will help surgeons reduce human errors and improve the quality of treatment. Surgeons can also use cryoablation, laser, and cryo energy-based ablation instead of RF-based ablation to treat individuals with arrhythmias. This will lead to the demand and use of sophisticated and advanced technologies-based ablation catheters. Such increasing demand will drive market growth during the forecast period.

Key Atrial Fibrillation Surgery Market Trend

The emergence of digital catheterization labs in hospitals is one of the key atrial fibrillation surgery market trends that is contributing to the market growth. Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. This system helps improve the detection and intervention of cardiac diseases, which assists physicians in performing coronary-related procedures in digital cath labs. These laboratories specialize in diagnostic services for outpatient procedures in hospitals, ASCs, and physicians clinics. The availability of a combination of cardiac catheterization for the ablation procedure and post-procedure recovery area in the same system can help minimize the overall associated expenses. Thus, the increasing establishment or improvement of digital cath labs worldwide will increase the adoption of cardiac ablation procedures in atrial fibrillation surgical procedures, which will drive the growth of the focused market during the forecast period.

Key Atrial Fibrillation Surgery Market Challenge

The high cost of ablation catheters is one of the factors hindering the atrial fibrillation surgery market growth. The use of catheter ablation for treating arrhythmias has led to the demand for advanced devices that can help improve the safety and effectiveness of associated procedures. However, most of these devices enabled with technologies such as 3D mapping, and remote catheter navigation are expensive. This deters individuals, particularly in developing countries, from undergoing catheter ablation procedures. Moreover, most hospitals and surgical centers worldwide perform less than 100 catheter ablation procedures per year, limiting the need for these high-end devices. Many countries such as the US, the UK, and Germany are shifting toward value-based purchasing to focus on the use of efficient devices and decrease the expenditure on medical facilities. Such challenges are limiting the market growth.

This atrial fibrillation surgery market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global atrial fibrillation surgery market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the atrial fibrillation surgery market during the forecast period.

Who are the Major Atrial Fibrillation Surgery Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Abbott Laboratories
• AtriCure Inc.
• BIOTRONIK SE and Co KG
• Boston Scientific Corp.
• CardioFocus Inc.
• General Electric Co.
• Johnson and Johnson
• Medtronic Plc
• Koninklijke Philips NV
• Siemens Healthineers AG
• MicroPort Scientific Corp.
• Boehringer Ingelheim International GmbH
• Stereotaxis Inc
• Tempus Labs Inc.
• Teleflex Inc.
• Lepu Medical Technology Beijing Co. Ltd.
• AngioDynamics Inc.
• Avanos Medical Inc.
• OSYPKA AG

 

This statistical study of the atrial fibrillation surgery market encompasses successful business strategies deployed by the key vendors. The atrial fibrillation surgery market is fragmented and the vendors are deploying growth strategies such as product launches and business expansions to compete in the market.

Product Insights and News

• Abbott Laboratories - Under the medical devices segment, the company offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. 
• Abbott Laboratories - The company offers flexAbility ablation catheter and sensor-enabled which is designed to facilitate detailed, accurate model creation and effective lesion creation and to yield safe, effective outcomes for patients. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The atrial fibrillation surgery market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Atrial Fibrillation Surgery Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the atrial fibrillation surgery market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Atrial Fibrillation Surgery Market?

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. The US is the key market for atrial fibrillation surgery market in North America. Market growth in this region will be faster than the growth of the market in ROW.

The rising prevalence of obesity will facilitate the atrial fibrillation surgery market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 had a positive impact on the regional market. Moreover, in the article 'Home Monitoring of Cardiac Devices in the Era of COVID-19,' published in 2020, the authors concluded that new technologies and digital platforms to aid in remote care should be developed and that more research on the role of telehealth, continuous data collection, advanced automotive features, and remote patient monitoring is needed to guide best practices, which could fuel the growth of the atrial fibrillation surgery market during the forecast period.

What are the Revenue-generating Product Segments in the Atrial Fibrillation Surgery Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The atrial fibrillation surgery market share growth by the catheter ablation segment will be significant during the forecast period. Catheter ablation is a procedure that destroys specific regions of the heart that cause cardiac rhythm issues. Catheters are thin, flexible wires that are threaded up the vein to the heart. Each catheter's electrode releases radio waves that cause heat, which destroys the heart tissues that cause a higher heart rate or cardiac arrhythmia. Arrhythmias can strike anyone at any age, but they are more common in the elderly. The operation can be done with prior electrophysiology (EP) testing, which allows clinicians to pinpoint the exact heart tissues having aberrant electrical pathways. When persons have persistently high heart rates and are resistant to pharmacological therapy, cardiac ablation catheters are frequently employed. Such applications are driving the segment growth.

This report provides an accurate prediction of the contribution of all the segments to the growth of the atrial fibrillation surgery market size and actionable market insights on post COVID-19 impact on each segment.

 

Atrial Fibrillation Surgery Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 14.17%
Market growth 2022-2026	$ 1.89 billion
Market structure	Fragmented
YoY growth (%)	13.54
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 37%
Key consumer countries	US, UK, Germany, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, AtriCure Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., CardioFocus Inc., General Electric Co., Johnson and Johnson, Medtronic Plc, Koninklijke Philips NV, Siemens Healthineers AG, MicroPort Scientific Corp., Boehringer Ingelheim International GmbH, Stereotaxis Inc, Tempus Labs Inc., Teleflex Inc., Lepu Medical Technology Beijing Co. Ltd., AngioDynamics Inc., Avanos Medical Inc., and OSYPKA AG
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Atrial Fibrillation Surgery Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive atrial fibrillation surgery market growth during the next five years
• Precise estimation of the atrial fibrillation surgery market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the atrial fibrillation surgery industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of atrial fibrillation surgery market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch